Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    The American journal of psychiatry · 2023
    IEImmanuel ElbauCJCharles Joseph LynchJPJonathan PowerNSNili SolomonovCLConor Liston
    PMID: 36855880PMCID: PMC11446248DOIFirst author103 citations

Publications

24 publications

Funding

5 grants

Active

4 grants
  • Co-I
    Precision mapping and neuromodulation of fronto-striatal-limbic brain circuits to identify mood switch mechanisms in bipolar disorder
    BD2 LLC · 2025–2028
    TMI 250797-01
  • Co-I
    An open-label trial of a novel prefrontal cortical interneuron-targeting antidepressant medication combination to achieve rapid antidepressant responses with minimal side effects
    Hope for Depression Research Foundation · 2026–2028
    HDRF 262807-01
  • Co-I
    Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression
    National Institute of Mental Health · 2024–2026
    UG3MH137656-01
  • PI
    Mapping individual network anatomy to DBS stimulation evoked behavioral responses in humans
    Brain & Behavior Research Foundation · 2023–2026
    BBRF 223941-02
Completed grants (1)
  • KP
    WELLCOME LEAP MARFA Master Contract - Personalized Therapeutic Neuromodulation for Anhedonic Depression
    Wellcome Leap, Inc. · 2021–2024
    WL 221649-01

Clinical research

1 study

Active

1 study
  • PI
    Neuromodulation of Mood Switch Circuitry in Bipolar Disorder
    PHASE4 · Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
    Bipolar Disorder (BD); Bipolar 1 Depression; rTMS; fMRI
    NCT07680153

News mentions

1 mentionView all WCM news ↗
  • Grant Supports Studies to Improve and Personalize Bipolar Care
    October 28, 2025

    A three-year, $4.5 million grant from BD²: Breakthrough Discoveries for thriving with Bipolar Disorder to Weill Cornell Medicine investigators, in collaboration with Stanford Medicine, will support a three-pronged research project to map the brain circuits that contribute to mood shifts in bipolar disorder and help develop personalized therapies for the condition.